Search images on Google      Product Monograph

Active Ingredients:

• sodium polystyrene sulfonate, 250 MG/ML

DIN: 00769541

Dosage Form(s): SUSPENSION

Route(s) of Administration: ORAL

Schedule: Prescription

Company: PENDOPHARM DIVISION OF PHARMASCIENCE INC

ATC:

• V03 - ALL OTHER THERAPEUTIC PRODUCTS (ATC, WHO, Wiki)
• V03A - ALL OTHER THERAPEUTIC PRODUCTS (ATC, WHO)
• V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia (ATC, WHO)
• V03AE01 - POLYSTYRENE SULPHONATE (WHO)

Reference brand drug: Kayexalate

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 60ML/500ML

Pharmaceutical standard: USP

 

External Links for Solystat:

Search on Google

• Solystat side effects
• Solystat dosage
• sodium polystyrene sulfonate side effects
• sodium polystyrene sulfonate dosage